Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kurt Gordon Pike, Cheshire GB
Kurt Gordon Pike, Cheshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080234273 | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes - Compounds of formula (I) | 09-25-2008 |
| 20080280872 | Benzamide Derivatives and Their Use as Glucokinase Activating Agents - Compounds of Formula (I): wherein: R | 11-13-2008 |
| 20080280874 | Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and Obesity - Compounds of Formula (I): | 11-13-2008 |
| 20080312207 | Compounds - Compounds of Formula (I) wherein: R1 is methyl; R2 is selected from —C (O) NR4R5, SO2NR4R5, S (O) pR4 and HET-2; HET-1 is a 5- or 6-membered, optionally substituted C-linked heteroaryl ring; HET-2 is a 4-, 5- or 6-membered, C- or N-linked optionally substituted heterocyclyl ring; R3 is selected from halo, fluoromethyl, difluoromethyl, trifluoromethyl, methyl, methoxy and cyano; R4 is selected from for example hydrogen, optionally substituted (1-4C) alkyl and HET-2; R5 is hydrogen or (1-4C) alkyl; or R4 and R5 together with the nitrogen atom to which they are attached may form a heterocyclyl ring system as defined by HET-3; HET-3 is for example an optionally substituted N-linked, 4, 5 or 6 membered, saturated or partially unsaturated heterocyclyl ring; p is (independently at each occurrence) 0, 1 or 2; m is 0 or 1; n is 0, 1 or 2; provided that when m is 0, then n is 1 or 2; or a salt, pro drug or solvate thereof, are described. Their use as GLK activators, pharmaceutical compositions containing them and processes for their preparation are also described. | 12-18-2008 |
| 20090018157 | Chemical compounds - Compounds of Formula (I) wherein: R | 01-15-2009 |
| 20090029905 | HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES - Compounds of formula (I) | 01-29-2009 |
| 20090062351 | Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators - A compound of Formula (I): Formula (I) wherein: R | 03-05-2009 |
| 20090105214 | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes - Compounds of formula (I), wherein R | 04-23-2009 |
| 20090105263 | HETEROBICYCLIC COMPOUNDS AS GLUCOKINASE ACTIVATORS - Compounds of Formula (I): | 04-23-2009 |
| 20090118159 | HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES - Compounds of formula (I) | 05-07-2009 |
| 20090253676 | Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes - Compounds of Formula (I): | 10-08-2009 |
| 20090264336 | HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES - Compounds of formula (I) | 10-22-2009 |
| 20110053910 | 2 -HETEROCYCLYLOXYBENZOYL AMINO HETEROCYCLYL COMPOUNDS AS MODULATORS OF GLUCOKINASE FOR THE TREATMENT OF TYPE 2 DIABETES - Compounds of formula (I) | 03-03-2011 |
| 20110059941 | 2-PHENYL SUBSTITUTED IMIDAZOL [4,5B] PYRIDINE/PYRAZINE AND PURINE DERIVATIVES AS GLUCOKINASE MODULATORS - Compounds of Formula (I), wherein R | 03-10-2011 |